Trokendi XR 50 mg Recall: Failed Dissolution
Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391…
What is the FDA recall status?
The FDA record lists this recall as ongoing. FDA enforcement data is not a live recall-lifecycle tracker. Follow the official instructions and check the agency notice or firm for current guidance.
Why was Trokendi XR 50 mg recalled?
Failed dissolution specifications.
What should I do if I have this product?
Follow the firm and FDA instructions for the affected product. Contact the recalling firm for current guidance.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare your product with the product description and available lot, UPC or model codes below from the official FDA record to check whether it is covered by this recall. If an identifier is missing or unclear, check the complete official notice or contact the firm; an incomplete match here does not establish that your product is unaffected.
Full product description
Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-102-30.
Which lot codes, UPCs or models are affected?
Lot# 2145283, Exp Date: 31-Mar-2030.
- Agency record number
- D-0833-2026
- Product
- Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391…
- Recalling firm
- Supernus Pharmaceuticals, Inc.
- Quantity
- 11304 bottles
- Distribution
- US Nationwide.
- Recall started
- August 31, 2026
- Report date
- September 9, 2026
- Classification
- Class III
- Status
- Ongoing
- Agency
- FDA (drug)